Potential role for vascular endothelial growth factor-D as an autocrine factor for human gastric carcinoma cells

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2121-2127

  Tanaka, Miwako ^a   Kitadai, Yasuhiko ^a   Kodama, Michiyo ^a   Shinagawa, Kei ^a   Sumida, Tomonori ^a   Tanaka, Shinji ^b   Oue, Naohide ^a   Yasui, Wataru ^a   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; PROTEIN BCL 2; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; KI 67 ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH WALL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DISEASE COURSE; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 77957069373     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01649.x     Document Type: Article

References (40)

1. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol 2006, 12:2979-90.
2. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002, 2:573-83.
3. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002, 2:795-803.
4. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-27.
5. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3:211-20.
6. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13:18-32.
7. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007, 38:258-68.
8. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 1996, 93:11675-80.
9. Stacker SA, Stenvers K, Caesar C. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1996, 274:32127-36.
10. Stacker SA, Caesar C, Baldwin ME. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001, 7:186-91.
11. Thelen A, Scholz A, Benckert C. VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 2008, 122:2471-81.
12. Von Marschall Z, Scholz A, Stacker SA. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 2005, 27:669-79.
13. White JD, Hewett PW, Kosuge D. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002, 62:1669-75.
14. Nakamura Y, Yasuoka H, Tsujimoto M. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res 2003, 9:716-21.
15. Kurahara H, Takao S, Maemura K, Shinchi H, Natsugoe S, Aikou T. Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. Clin Cancer Res 2004, 10:8413-20.
16. Yokoyama Y, Charnock-Jones DS, Licence D. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer 2003, 88:237-44.
17. Yokoyama Y, Charnock-Jones DS, Licence D. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 2003, 9:1361-9.
18. Jüttner S, Wissmann C, Jöns T. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006, 24:228-40.
19. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000, 6:2431-9.
20. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001, 92:556-68.
21. George ML, Tutton MG, Janssen F. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 2001, 3:420-7.
22. Onogawa S, Kitadai Y, Tanaka S, Kuwai T, Kimura S, Chayama K. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 2004, 95:32-9.
23. Kitadai Y, Kodama M, Cho S. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes. Int J Cancer 2005, 115:388-92.
24. Kodama M, Kitadai Y, Tanaka M. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanism. Clin Cancer Res 2008, 14:7205-14.
25. Japanese Classification of Gastric Carcinoma 1999, Kanehara & Co., Tokyo
26. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8.
27. Joukov V, Pajusola K, Kaipainen A. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-8.
28. Achen MG, Jeltsch M, Kukk E. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998, 95:548-53.
29. Kopfstein L, Veikkola T, Djonov VG. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol 2007, 170:1348-61.
30. Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 2004, 46:11-19.
31. Timoshenko AV, Rastogi S, Lala PK. Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells. Br J Cancer 2007, 97:1090-8.
32. Von Marschall Z, Cramer T, Höcker M. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. Gastroenterology 2000, 119:1358-72.
33. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002, 62:7203-6.
34. Jackson MW, Roberts JS, Heckford SE. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 2002, 62:854-9.
35. Mäkinen T, Veikkola T, Mustjoki S. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2002, 20:4762-73.
36. Veikkola T, Jussila L, Makinen T. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001, 20:1223-31.
37. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005, 7:121-7.
38. Karpanen T, Alitalo K. Lymphatic vessels as targets of tumor therapy? J Exp Med 2001, 194:F37-42.
39. Folkman J. Looking for a good endothelial address. Cancer Cell 2002, 1:113-15.
40. Akahane M, Akahane T, Matheny SL, Shah A, Okajima E, Thorgeirsson UP. Vascular endothelial growth factor-D is a survival factor for human breast carcinoma cells. Int J Cancer 2006, 118:841-9.